Myti M. J. van Staveren op LinkedIn: #paulientichelaar #philippecoville #yvettebotvleerlaag #svenforstman… (2024)

https://lnkd.in/eVCWTpUU

https://lnkd.in/eVCWTpUU

Beatrice Golomb, prof aan de universiteit in San Diego. Californië.. https://lnkd.in/eEcvAK_U

1

FQAD – FQAD Support (fqad-support.com)

2

2

Overview of Side-Effects of Antibacterial Fluoroquinolones: New Drugs versus Old Drugs, a Step Forward in the Safety Profile?: Zie artikel: https://lnkd.in/eYcmF5ym

1

1 commentaar

Fluoroquinolone-Associated Disability (FQAD) - Pathogenesis, Diagnostics, Therapy and Diagnostic Criteria. Doctor Stefan Pieper. Germany. Universiteit van Berlijn.https://lnkd.in/ePYzifPxhttps://lnkd.in/enGDfq5RDr. med. Stefan Pieperhas been working in a practice for integrative medicine with a focus on mitochondrial medicine, acupuncture, nutrition and homeopathy for 25 years. During his time at the clinic, he worked for many years in internal medicine, anaesthesia and neonatal intensive care units. He is a paramedic and holds a British Diploma in Anaesthesia.Dr. Pieper developed a diagnostic tool for the reliable detection of FQAD and he is one of the most experienced therapists in this field. With over 500 FQAD patients treated, he has an exceptionally high level of expertise.Currently he is working together with the Centrum für Herz-, Kreislauf- und Gefäßmedizin, University of Berlin, Charité, on a study regarding the use of Fluoroquinolones and the risk of aortic aneurysm and dissection.

1

Het is even geleden sinds ik mijn MD, (niet praktiserend, gepensioneerd) aan Universiteit van Amsterdam/Erasmus Universiteit Rotterdam heb voltooid, maar ik wilde deze update met iedereen delen.

Deze content is hier niet beschikbaar

Open deze content en meer in de LinkedIn-app

Fluoroquinolones-Associated Disability (GQAD): It Is Not All in Your Head: byMaya Z. Freeman, Deanna N. Cannizzaro,Lydia F. Naughtonand Cecilia Bove.Department of Biology, Bucknell University, Lewisburg, PA 17837, USA.*Abstract:Fluoroquinolones (FQs) are a broad class of antibiotics typically prescribed for bacterial infections, including infections for which their use is discouraged. The FDA has proposed the existence of a permanent disability (Fluoroquinolone Associated Disability; FQAD), which is yet to be formally recognized. Previous studies suggest that FQs act as selective GABAAreceptor inhibitors, preventing the binding of GABA in the central nervous system. GABA is a key regulator of the vagus nerve, involved in the control of gastrointestinal (GI) function. Indeed, GABA is released from the Nucleus of the Tractus Solitarius (NTS) to the Dorsal Motor Nucleus of the vagus (DMV) to tonically regulate vagal activity. The purpose of this review is to summarize the current knowledge on FQs in the context of the vagus nerve and examine how these drugs could lead to dysregulated signaling to the GI tract. Since there is sufficient evidence to suggest that GABA transmission is hindered by FQs, it is reasonable to postulate that the vagal circuit could be compromised at the NTS-DMV synapse after FQ use, possibly leading to the development of permanent GI disorders in FQAD.Keywords:fluoroquinolones;fluoroquinolones-associated-disability;vagus;gastrointestinal;digestion;DMV;NTS;FQAD